FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186368334> ?p ?o ?g. }

• W3186368334 endingPage "3749" @default.
• W3186368334 startingPage "3749" @default.
• W3186368334 abstract "Triple-negative breast cancers (TNBCs) are highly aggressive and recurrent. Standard cytotoxic chemotherapies are currently the main treatment options, but their clinical efficacies are limited and patients usually suffer from severe side effects. The goal of this study was to develop and evaluate targeted liposomes-delivered combined chemotherapies to treat TNBCs. Specifically, the IC50 values of the microtubule polymerization inhibitor mertansine (DM1), mitotic spindle assembly defecting taxane (paclitaxel, PTX), DNA synthesis inhibitor gemcitabine (GC), and DNA damage inducer doxorubicin (AC) were tested in both TNBC MDA-MB-231 and MDA-MB-468 cells. Then we constructed the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) tagged liposomes and confirmed its TNBC cell surface binding using flow cytometry, internalization with confocal laser scanning microscopy, and TNBC xenograft targeting in NSG female mice using In Vivo Imaging System. The safe dosage of anti-EGFR liposomal chemotherapies, i.e., <20% body weight change, was identified. Finally, the in vivo anti-tumor efficacy studies in TNBC cell line-derived xenograft and patient-derived xenograft models revealed that the targeted delivery of chemotherapies (mertansine and gemcitabine) can effectively inhibit tumor growth. This study demonstrated that the targeted liposomes enable the new formulations of combined therapies that improve anti-TNBC efficacy." @default.
• W3186368334 created "2021-08-02" @default.
• W3186368334 creator A5001842004 @default.
• W3186368334 creator A5022429262 @default.
• W3186368334 creator A5035825393 @default.
• W3186368334 creator A5042525407 @default.
• W3186368334 creator A5048689879 @default.
• W3186368334 creator A5065215252 @default.
• W3186368334 creator A5072315367 @default.
• W3186368334 creator A5074339191 @default.
• W3186368334 creator A5075553640 @default.
• W3186368334 creator A5082669345 @default.
• W3186368334 creator A5086328329 @default.
• W3186368334 date "2021-07-26" @default.
• W3186368334 modified "2023-10-03" @default.
• W3186368334 title "Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer" @default.
• W3186368334 cites W100143889 @default.
• W3186368334 cites W1508613957 @default.
• W3186368334 cites W1551168702 @default.
• W3186368334 cites W1630018437 @default.
• W3186368334 cites W1837617056 @default.
• W3186368334 cites W1922064584 @default.
• W3186368334 cites W1927418631 @default.
• W3186368334 cites W1970462717 @default.
• W3186368334 cites W1986783732 @default.
• W3186368334 cites W1987057670 @default.
• W3186368334 cites W1988055795 @default.
• W3186368334 cites W1997446043 @default.
• W3186368334 cites W2000610587 @default.
• W3186368334 cites W2001146639 @default.
• W3186368334 cites W2005867761 @default.
• W3186368334 cites W2006394078 @default.
• W3186368334 cites W2007063468 @default.
• W3186368334 cites W2013521436 @default.
• W3186368334 cites W2049515588 @default.
• W3186368334 cites W2051120695 @default.
• W3186368334 cites W2054566577 @default.
• W3186368334 cites W2055553083 @default.
• W3186368334 cites W2061001563 @default.
• W3186368334 cites W2087688974 @default.
• W3186368334 cites W2094489962 @default.
• W3186368334 cites W2099335989 @default.
• W3186368334 cites W2100183121 @default.
• W3186368334 cites W2101027485 @default.
• W3186368334 cites W2103761158 @default.
• W3186368334 cites W2120210375 @default.
• W3186368334 cites W2120239384 @default.
• W3186368334 cites W2136776783 @default.
• W3186368334 cites W2141101181 @default.
• W3186368334 cites W2155384808 @default.
• W3186368334 cites W2176440290 @default.
• W3186368334 cites W2297492093 @default.
• W3186368334 cites W2344995542 @default.
• W3186368334 cites W2409420104 @default.
• W3186368334 cites W2430731787 @default.
• W3186368334 cites W2530480480 @default.
• W3186368334 cites W2574305039 @default.
• W3186368334 cites W2606308933 @default.
• W3186368334 cites W2614154488 @default.
• W3186368334 cites W2728962997 @default.
• W3186368334 cites W2743804580 @default.
• W3186368334 cites W2764025270 @default.
• W3186368334 cites W2775469584 @default.
• W3186368334 cites W2783930641 @default.
• W3186368334 cites W2794370011 @default.
• W3186368334 cites W2804338027 @default.
• W3186368334 cites W2809085265 @default.
• W3186368334 cites W2885221819 @default.
• W3186368334 cites W2887583339 @default.
• W3186368334 cites W2896602650 @default.
• W3186368334 cites W2911997260 @default.
• W3186368334 cites W2914211747 @default.
• W3186368334 cites W2919631338 @default.
• W3186368334 cites W2920930944 @default.
• W3186368334 cites W2939344653 @default.
• W3186368334 cites W2942446910 @default.
• W3186368334 cites W2943185278 @default.
• W3186368334 cites W2965572827 @default.
• W3186368334 cites W2969263349 @default.
• W3186368334 cites W2973681978 @default.
• W3186368334 cites W2979546061 @default.
• W3186368334 cites W2981801813 @default.
• W3186368334 cites W2982706960 @default.
• W3186368334 cites W2993001987 @default.
• W3186368334 cites W2994214872 @default.
• W3186368334 cites W2997542870 @default.
• W3186368334 cites W2998375205 @default.
• W3186368334 cites W3003322622 @default.
• W3186368334 cites W3036737182 @default.
• W3186368334 cites W3042821292 @default.
• W3186368334 cites W3092625347 @default.
• W3186368334 cites W3103442181 @default.
• W3186368334 cites W3138192222 @default.
• W3186368334 cites W3158998856 @default.
• W3186368334 cites W4385789423 @default.
• W3186368334 doi "https://doi.org/10.3390/cancers13153749" @default.
• W3186368334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8345094" @default.
• W3186368334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34359650" @default.

• next